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Abstract: BACKGROUND Gingival recessions inevitably occur during healing after scaling and root
planing, but synoptic data on this topic is still lacking. This review compared the recession formation
with and without the administration of systemic antibiotics. OBJECTIVES To evaluate the formation
of recession with and without the administration of antibiotics during the healing after scaling and root
planing. MATERIALS AND METHODS This study re-analyzed publications that reported clinical at-
tachment levels (CAL) and probing pocket depths (PD) up to January 2019, including the pivotal review
by Zandbergen and co-workers (2013). Whereas these studies traditionally focused on PD and CAL,
the present analysis compared recession formation (ΔREC) after adjunctive systemic administration of
amoxicillin (amx) and metronidazole (met) during scaling and root planing (SRP) and SRP alone. The
mean increase in ΔREC, if not reported, was calculated from CAL and PD values and statistically an-
alyzed. Recession formation was compared after 3 and 6 months after therapy. Results were separately
reported for chronic periodontitis (CP) as well as aggressive periodontitis (AP) cases. RESULTS Reces-
sions increased consistently between baseline and follow-up. In the AP group, median ΔREC was 0.20
mm after 3 months, irrespective of whether antibiotics were administered or not. After 6 months, median
ΔREC increased to 0.35 mm after AB and remained stable at 0.20 mm with SRP alone. In the CP group,
after 3 months with and without antibiotics, median ΔREC accounted for 0.30 mm and 0.14 mm, respec-
tively. After 6 months, median ΔREC accounted for 0.28 mm (with AB) and 0.20 mm (without AB).
The quantitative assessment by meta-analyses also yielded small values (฀ 0.25 mm) for the estimated
differences in recession formation between AB and noAB; however, none of them reached statistical sig-
nificance. CONCLUSIONS Although a slight tendency towards higher recession formation after SRP in
combination with AB could be observed in many studies, quantitative meta-analyses showed no clinically
relevant difference in recession formation due to the administration of AB. In general, the description and
discussion of recessions in the literature seems not to be a major focus so far. CLINICAL RELEVANCE
Since the preservation of gingival tissues is important by preventive and therapeutic means, e.g., when
avoiding postoperative root sensitivity or performing regenerative surgery, these aspects should not be
neglected. We thus suggest to report REC measurements along with PD and CAL values for more direct
recession formation (ΔREC) assessments in the future.
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Abstract 
Background: Gingival recessions inevitably occur during healing after scaling and root planing, 
but synoptic data on this topic is still lacking. This review compared the recession formation 
with and without the administration of systemic antibiotics. 
Objectives: To evaluate the formation of recession with and without the administration of 
antibiotics during the healing after scaling and root planing. 
Materials and Methods: This study re-analyzed publications that reported clinical attachment 
levels (CAL) and probing pocket depths (PD) up to January 2019, including the pivotal review by 
Zandbergen and co-workers (2013). Whereas these studies traditionally focused on PD and CAL, 
the present analysis compared recession formation (DREC) after adjunctive systemic 
administration of amoxicillin (amx) and metronidazole (met) during scaling and root planing 
(SRP) and SRP alone. The mean increase in DREC, if not reported, was calculated from CAL and 
PD values and statistically analyzed. Recession formation was compared after three and six 
months after therapy. Results were separately reported for chronic periodontitis (CP) as well as 
aggressive periodontitis (AP) cases. 
Results: Recessions increased consistently between baseline and follow-up. In the AP group, 
median DREC was 0.20 mm after 3 months, irrespective of whether antibiotics were 
administered or not. After six months, median DREC increased to 0.35 mm after AB and 
remained stable at 0.20 mm with SRP alone. In the CP group, after three months with and 
without antibiotics, median DREC accounted for 0.30 mm and 0.14 mm, respectively. After six 
months, median DREC accounted for 0.28 mm (with AB) and 0.20 mm (without AB). The 
quantitative assessment by meta-analyses also yielded small values (£ 0.25 mm) for the 
estimated differences in recession formation between AB and noAB, however, none of them 
reached statistical significance.  
Conclusions: Although a slight tendency towards higher recession formation after SRP in 
combination with AB could be observed in many studies, quantitative meta-analyses showed 
no clinically relevant difference in recession formation due to the administration of AB. In 
general, the description and discussion of recessions in the literature seems not to be a major 
focus so far.  
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Clinical relevance: Since the preservation of gingival tissues is important by preventive and 
therapeutic means, e.g. when avoiding postoperative root sensitivity or performing 
regenerative surgery, these aspects should not be neglected. We thus suggest to report REC 
measurements along with PD and CAL values for more direct recession formation (DREC) 





Keywords: Scaling and root planing, debridement, clinical attachment level, periodontal 
healing, systemic antibiotics  
 4 
Background 
Recessions (REC) inevitably occur in the area of the inflamed gingival zone after thorough 
cleaning and in due course of successful healing, mainly due to the reduction of the swelling 
and shrinkage of the tissues [1]. Especially in severe cases with deep pockets, recession 
formation (DREC) may be even accentuated. It has been shown that gingival REC increase from 
shallow pockets (≤ 3 mm) to moderately deep (4-6 mm) and deep sites (≥ 7 mm) from 1 mm 
over 1.2 to 1.9 mm, respectively [1], [2]. Studies have also shown that neither repeated 
instrumentation nor operator variability influence DREC [3], [4]. Flat surfaces on either single-
rooted or flat molar teeth, however, show more REC than furcation-associated sites [5]. This 
illustrates the interplay between a lack of cleaning efficacy and cleaning accessibility and 
therefore decreased inflammation management and consequently less tissue shrinkage; vice 
versa, better cleaning (efficacy and accessibility) leads to more DREC. A plethora of strategies 
have been introduced including mechanical, physical and chemical adjuncts to improve the 
results after conventional SRP procedures. Among these suggested alternatives, no option has 
proven better efficacy or effectiveness so far than the adjunctive use of systemic antibiotics 
(AB) combination therapy like amoxicillin (amx) and metronidazole (met) for example [6]. 
Several systematic reviews and meta-analyses have impressively shown its superiority in this 
context so far; as well as for AP and CP [7]. However, most studies and reviews have mainly 
focused on PD and CAL and their respective losses, gains and the measurement of differences 
so far. These primary outcome parameters, however, still remain difficult to translate into 
clinically relevant treatment outcomes, especially if only means and standard deviations are 
depicted. Therefore, research has also focused on alternative measurements, such as the 
percentage of remaining pockets as such [8]. Unfortunately, the topic of DREC after non-surgical 
periodontal therapy has not yet gained much attention in this regard; especially not in the 
context of systemic AB usage. However, it might be of special clinical interest to oversee and 
estimate differences regarding DREC in the light of preventive and therapeutic considerations. 
For example in order to avoid postoperative root sensitivity and caries or when dealing with 
severe cases, which may still require surgical intervention after SRP including regenerative 
approaches. Particularly in the latter cases, any loss of marginal soft tissue should be considered 
as a shortcoming: The preservation of the marginal soft tissue height at facial and interproximal 
aspects remains of outmost clinical interest in order to achieve optimal clinical results, since 
any lost tissue is difficult to restore again and wound closure may be complicated. 
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Therefore, the aim of the present re-review was to investigate whether there are potential 
differences in DREC after administration of AB, i.e. amoxicillin (amx) and metronidazole (met) 
during SRP as compared to SRP alone. For this purpose, papers and data included in the meta-
analysis by Zandbergen et al. [7] and other studies [9], [10], [11], [12], [13], [14], [15] were re-
analyzed in order to calculate sensible estimates for REC values from PD and CAL measurements 
and quantitatively assess them by meta-analyses. The literature was updated and 
supplemented up to January 17th, 2019. Our working hypothesis was that the use of systemic 
AB would lead to increased DREC in both, CP and AP cases, 3 and 6 months after SRP.  
 
Methods 
The present re-review was based on the 28 studies, which were originally selected for inclusion 
in a systematic review by Zandbergen et al. [7]. This high-quality publication followed the 
guidelines of Transparent Reporting of Systematic Reviews and Meta-analyses (PRISMA-
statement) [16]. The original internet search included MEDLINE-PubMed, EMBASE and 
Cochrane-CENTRAL as databases. Language restrictions were set to English and Dutch. The 
focused question of the latter publication was adapted in the present study as follows: 
„In patients with periodontitis what is the effect of adjunctive systemic administration of amx 
and met to SRP as compared to SRP alone with respect DREC?“ 
For details regarding quality assessment, data extraction and grading of the body of evidence, 
we also refer to the original article [7]. 
In addition to the existing review [7] an original internet search using identic search terms and 
databases was performed from April 1st, 2012 until January 17th, 2019. For specific search terms 
and search strategy, cf. Figure 1. The update of the systematic review was also conducted in 
accordance with the PRISMA guidelines [16]. Table 1 illustrates the characteristics of the 
included studies for meta-analysis (n = 16) and Table 2 shows summary statistics of the target 
variable DREC across the studies. 
 
Data preparation 
Data on original REC values were not available for most included studies. Therefore, mean 
recession 𝑅𝐸𝐶  at a given time was assessed as the difference between the reported mean 
clinical attachment level 𝐶𝐴𝐿  and mean pocked depth 𝑃𝐷 , using the additive property of 
expectations 𝐸(𝑅𝐸𝐶) = 𝐸(𝐶𝐴𝐿 − 𝑃𝐷) = 𝐸(𝐶𝐴𝐿) − 𝐸(𝑃𝐷). Hence, the mean recession 
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formation (∆𝑅𝐸𝐶) between baseline (𝐵𝐿) and followup (𝐹𝑈) was calculated for each study for 
both groups (AB, noAB), again using the additivity property: 
𝐸(∆𝑅𝐸𝐶) = 	𝐸(𝑅𝐸𝐶23) − 𝐸(𝑅𝐸𝐶45)    (1) 
The variance for ∆𝑅𝐸𝐶 for each study was assessed according to the equation of Bienaymé [17]. 
𝑉𝑎𝑟(∆𝑅𝐸𝐶) = 𝑉𝑎𝑟(𝑅𝐸𝐶45) + 𝑉𝑎𝑟(𝑅𝐸𝐶23)   (2) 
Thus, our approach neglects potential covariance between 𝐶𝐴𝐿 and 𝑃𝐷, as well as between 
𝑅𝐸𝐶23  and 𝑅𝐸𝐶45, because these values were not reported and it would require patient-level 
information to estimate them correctly. However, the estimates for mean ∆𝑅𝐸𝐶  are not 
affected, and merely the variances for ∆𝑅𝐸𝐶  are potentially too large, i.e. potentially too 
conservative. We thus deemed these simple calculations appropriate for a first assessment of 
a potential antibiotic effect on REC, considering the current scarcity of data in the literature.    
 
Meta-analyses 
The calculated means and variances for DREC in combination with the respective sample sizes 
were then entered in a fixed and random effects meta-analysis model, using the metaphor  
package in R [18], [19]. 
Four separate meta-analyses for the mean difference in DREC (∆𝑅𝐸𝐶:;<4 − ∆𝑅𝐸𝐶<4) between 
AB and noAB treatment were conducted: at 3 months and 6 months follow-up for the AP and 
the CP subset. In all cases, the heterogeneity parameter in the random effects model could not 
be satisfactorily assessed or was estimated to be zero, therefore the fixed effects model was 
chosen. Model assumptions were checked using residuals, funnel and radial plots.   
   
Results 
Considering the summary statistics (Table 2), REC increased consistently between baseline and 
follow-up. In the AP group, irrespective of whether AB were administered or not, median DREC 
was 0.20 mm. After six months, DREC increased to 0.35 mm with AB and remained stable at 
0.20 mm with SRP alone. In the CP group after three months with AB and without AB, the 
median differences accounted for 0.30 mm and 0.14 mm, respectively. After six months, 
median DREC accounted for 0.28 mm (with AB) and 0.20 mm (without AB). 
After 3 months, two out of five studies with AP showed slightly higher values for DREC without 
the use of AB, six out of seven considered studies dealing with CP showed more DREC when 
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using AB. After 6 months, five out of eight studies with AP and 2 out of five studies in the CP 
group showed larger DREC with AB. 
None of the meta-analyses showed a significant effect with respect to the difference in DREC 
between AB and noAB treatment. In case of the AP group, the mean difference in DREC 
(∆𝑅𝐸𝐶:;<4 − ∆𝑅𝐸𝐶<4) was estimated to be 0.17 mm (95% CI: -0.02, 0.35) after 3 months and 
-0.01 mm (95% CI: -0.19, 0.17) after 6 months, demonstrating a minimally larger REC increase 
for the noAB and AB group after the different follow-up times, respectively (Figure 3 [20], [21], 
[22], [23], [12] and 4 [20], [21], [22], [23], [14], [24], [25]). The differences between DREC for 
the CP group were estimated to be -0.25 mm (95% CI: -0.60, 0.09) after 3 months and -0.04 
(95% CI: -0.43, 0.36) after 6 months, also not yielding any significant difference, but with a more 
accentuated pattern, which possibly suggests a slightly higher REC increase for the AB group 
(Figure 5 [26], [27], [15], [13], [11], [10], [9] and Figure 6 [15], [13], [11], [10], [9]). However, this 
pattern could also be due to a slight publication bias as the smallest studies show the largest 
effects (cf. Figure 5). Using the meta-analysis approach, the estimated differences in DREC 
between AB and noAB were thus always small, i.e. £ 0.25 mm. 
 
Discussion 
This re-review calculated the DREC from available PD and CAL values in the literature and 
compared non-surgical periodontal therapy with systemic AB (amoxicillin/metronidazole) to 
SRP alone after 3 and 6 months for CP and AP cases. Moreover, respective meta-analyses were 
conducted to quantitatively assess the potential differences in DREC. 
The data set in this study comprised studies of a previously published meta-analysis [7], which 
served as the basis for our re-analysis. Notably, the underlying set of literature was identical 
but in the present study we focused on the REC outcome parameter, which was unfortunately 
not directly assessed so far, neither in the included individual studies nor – as a consequence – 
in other reviews. The data on REC first had to be calculated from the reported CAL and PD 
measurements, i.e. from the differences between these two parameters. Accepting relatively 
conservative standard errors, the statistical methodology to achieve the clinical parameter of 
DREC over time was straightforward. 
As a general finding, a slight tendency towards higher DREC after SRP in combination with AB 
was found as compared to SRP alone in many studies. However, using the meta-analyses, 
estimated differences between the use of AB and noAB with regard to DREC yielded rather small 
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values for the estimated difference between the treatments, and none of them reached 
statistical significance. At first sight, the difference between the SRP treatment with and 
without AB would therefore not appear to be clinically relevant, since the largest estimated 
difference in DREC was only 0.25 mm (between AB and noAB in CP after 3 months). 
Nevertheless, the calculated differences should be related to the overall PD reduction and the 
additional CAL gain with observed mean values of -0.47 mm and +0.33 mm, respectively [28]. 
These values were also below 0.5 mm and one should acknowledge in this context the fact that 
the results are based on calculations related to multiple (also non-diseased) sites, which may 
dilute the actual effect.  
In general, DREC after non-surgical therapy depends on the initial PD and may slightly increase 
during maintenance over time [29]. Long-term studies showed that REC decreased again over 
time, especially after surgical treatment [30]. The present study was limited to 3 and 6 months. 
However, from a clinical perspective, this time frame is relevant after non-surgical therapy, at 
least in terms of further decision making and most probably also in view of the initial tissue 
response and tissue shrinkage [2], [1]. The systemically determined difference between the AB 
and noAB treatment was shown to be rather small with absolute values around 0.00 - 0.25 mm, 
although in practice, the clinical outcome may strongly depend on the type of patient and 
diagnosis and thus show large inter-patient variability. Unfortunately, there is very little 
published data available from directly measurements and reporting REC after SRP. A study in 
CP patients reported DREC values after 3 and 6 months after non-surgical therapy with AB of 
2.2 and 2.0 mm and 1.5 and 1.4 mm without AB [31].  
Within the limitations of our re-review, the results should be interpreted with caution due to 
the presence of uncontrolled confounding factors in the included studies such as different 
dosage and time of the AB or unreported smoking status of the patients.  
In summary, reporting REC values still seems to be of minor interest to researchers, except in 
studies where regenerative products are used and where REC appears more appropriate as a 
relevant surrogate parameter for shrinkage and tissue height. In our opinion, REC represents an 
important and valuable measure for judging the clinical outcome of any successful periodontal 
therapy. The unavoidable side-effect of the healing process, i.e. recession formation, may even 
lead to a reduction of patient’s perception of oral health related quality of life (OHQoL) [32]. 
Patients only realize what the esthetic outcome of recession formation (papilla loss (aesthetics), 
dentin hypersensitivity or enhanced risk of root caries) means for them personally once 
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treatment is completed and additional therapy needs may emerge. Also, for clinicians, it is quite 
a daunting task to balance the therapy goals with acceptable endpoints for the individual 
patient regarding recession. Therefore, we recommend further investigations in this direction 
and adequate reporting on this relevant periodontal parameter as well. More original data and 
respective reviews are still warranted and further research on this topic may lead to new 
insights as well as optimized treatments in view of esthetic outcomes. 
 
Conclusion 
Although a slight tendency towards higher DREC after SRP in combination with AB could be 
observed as compared to SRP alone in many studies, quantitative meta-analyses showed no 
clinically relevant difference in DREC due to the administration of AB. Since the preservation of 
(healthy) gingival tissues is one of the major therapeutic goals in periodontology and is also 
important by preventive and therapeutic means, the aspect of DREC should not be neglected. 
We thus suggest to report REC measurements along with PD and CAL values in future studies 







Compliance with Ethical Standards 
 
Conflict of interest 
The authors declare that they have no conflict of interest.  
 
Funding 
No funding has been available other than that of the authors’ institution. 
 
Ethical approval  
This article does not contain any studies with human participants or animals performed by any 
of the authors. 
 
Informed consent 
For this type of study, formal consent is not required. 
 
Availability of data and materials 




PRS conceived the study and supervised the study. DW did the statistical evaluation of the 
papers and participated in its design. MK did the literature search. MK, AS and UZ drafted the 
manuscript. TA helped to supervise the methodological correctness of the performed study and 
the coordination. All authors carefully read and approved the final text.  
 
Acknowledgment 
The authors would like to thank Mrs. Dr. Sabine Klein, librarian of the main library of the 
University of Zurich who performed the electrical literature search.  






1. ADRIAENS, P. A., AND L. M. ADRIAENS. 2004. EFFECTS OF NONSURGICAL PERIODONTAL THERAPY ON HARD AND SOFT 
TISSUES. PERIODONTOL 2000 36: 121-145. 
2. COBB, C. M. 1996. NON-SURGICAL POCKET THERAPY: MECHANICAL. ANN PERIODONTOL 1: 443-490. 
3. BADERSTEN, A., R. NILVEUS, AND J. EGELBERG. 1984. EFFECT OF NONSURGICAL PERIODONTAL THERAPY. III. SINGLE 
VERSUS REPEATED INSTRUMENTATION. J CLIN PERIODONTOL 11: 114-124. 
4. BADERSTEN, A., R. NILVÉUS, AND J. EGELBERG. 1985. EFFECT OF NON-SURGICAL PERIODONTAL THERAPY (IV). 
OPERATOR VARIABILITY. J CLIN PERIODONTOL 12: 190-200. 
5. CLAFFEY, N., K. NYLUND, R. KIGER, S. GARRETT, AND J. EGELBERG. 1990. DIAGNOSTIC PREDICTABILITY OF SCORES OF 
PLAQUE, BLEEDING, SUPPURATION AND PROBING DEPTH FOR PROBING ATTACHMENT LOSS. 3 1/2 YEARS OF 
OBSERVATION FOLLOWING INITIAL PERIODONTAL THERAPY. J CLIN PERIODONTOL 17: 108-114. 
6. MOMBELLI, A. 2018. MICROBIAL COLONIZATION OF THE PERIODONTAL POCKET AND ITS SIGNIFICANCE FOR 
PERIODONTAL THERAPY. PERIODONTOL 2000 76: 85-96. 
7. ZANDBERGEN, D., D. E. SLOT, C. M. COBB, AND F. A. VAN DER WEIJDEN. 2013. THE CLINICAL EFFECT OF SCALING AND 
ROOT PLANING AND THE CONCOMITANT ADMINISTRATION OF SYSTEMIC AMOXICILLIN AND METRONIDAZOLE: A 
SYSTEMATIC REVIEW. J PERIODONTOL 84: 332-351. 
8. KOLAKOVIC, M., U. HELD, P. R. SCHMIDLIN, AND P. SAHRMANN. 2014. AN ESTIMATE OF POCKET CLOSURE AND AVOIDED 
NEEDS OF SURGERY AFTER SCALING AND ROOT PLANING WITH SYSTEMIC ANTIBIOTICS: A SYSTEMATIC REVIEW. BMC 
ORAL HEALTH 14: 159. 
9. THEODORO, L. H., N. Z. ASSEM, M. LONGO, M. L. F. ALVES, C. DUQUE, R. N. STIPP, N. L. VIZOTO, AND V. G. GARCIA. 2018. 
TREATMENT OF PERIODONTITIS IN SMOKERS WITH MULTIPLE SESSIONS OF ANTIMICROBIAL PHOTODYNAMIC THERAPY 
OR SYSTEMIC ANTIBIOTICS: A RANDOMIZED CLINICAL TRIAL. PHOTODIAGNOSIS PHOTODYN THER 22: 217-222. 
10. BORGES, I., M. FAVERI, L. C. FIGUEIREDO, P. M. DUARTE, B. RETAMAL-VALDES, S. C. L. MONTENEGRO, AND M. FERES. 
2017. DIFFERENT ANTIBIOTIC PROTOCOLS IN THE TREATMENT OF SEVERE CHRONIC PERIODONTITIS: A 1-YEAR 
RANDOMIZED TRIAL. J CLIN PERIODONTOL 44: 822-832. 
11. COSGAREA, R., R. JUNCAR, C. HEUMANN, R. TRISTIU, L. LASCU, N. ARWEILER, A. STAVROPOULOS, AND A. SCULEAN. 
2016. NON-SURGICAL PERIODONTAL TREATMENT IN CONJUNCTION WITH 3 OR 7 DAYS SYSTEMIC ADMINISTRATION OF 
AMOXICILLIN AND METRONIDAZOLE IN SEVERE CHRONIC PERIODONTITIS PATIENTS. A PLACEBO-CONTROLLED 
RANDOMIZED CLINICAL STUDY. J CLIN PERIODONTOL 43: 767-777. 
12. TAIETE, T., M. Z. CASATI, É. P. RIBEIRO, E. A. SALLUM, F. H. NOCITI JÚNIOR, AND R. C. CASARIN. 2016. 
AMOXICILLIN/METRONIDAZOLE ASSOCIATED WITH NONSURGICAL THERAPY DID NOT PROMOTE ADDITIONAL BENEFITS 
IN IMMUNOLOGIC PARAMETERS IN GENERALIZED AGGRESSIVE PERIODONTITIS: A RANDOMIZED CONTROLLED CLINICAL 
TRIAL. QUINTESSENCE INT 47: 281-292. 
13. MIRANDA, T. S., M. FERES, P. J. PEREZ-CHAPARRO, M. FAVERI, L. C. FIGUEIREDO, N. S. TAMASHIRO, M. F. BASTOS, AND 
P. M. DUARTE. 2014. METRONIDAZOLE AND AMOXICILLIN AS ADJUNCTS TO SCALING AND ROOT PLANING FOR THE 
TREATMENT OF TYPE 2 DIABETIC SUBJECTS WITH PERIODONTITIS: 1-YEAR OUTCOMES OF A RANDOMIZED PLACEBO-
CONTROLLED CLINICAL TRIAL. J CLIN PERIODONTOL 41: 890-899. 
14. LIRA, E. A., F. S. RAMIRO, F. M. CHIARELLI, R. R. DIAS, M. FERES, L. C. FIGUEIREDO, AND M. FAVERI. 2013. REDUCTION IN 
PREVALENCE OF ARCHAEA AFTER PERIODONTAL THERAPY IN SUBJECTS WITH GENERALIZED AGGRESSIVE 
PERIODONTITIS. AUST DENT J 58: 442-447. 
15. FERES, M., G. M. SOARES, J. A. MENDES, M. P. SILVA, M. FAVERI, R. TELES, S. S. SOCRANSKY, AND L. C. FIGUEIREDO. 2012. 
METRONIDAZOLE ALONE OR WITH AMOXICILLIN AS ADJUNCTS TO NON-SURGICAL TREATMENT OF CHRONIC 
PERIODONTITIS: A 1-YEAR DOUBLE-BLINDED, PLACEBO-CONTROLLED, RANDOMIZED CLINICAL TRIAL. J CLIN 
PERIODONTOL 39: 1149-1158. 
16. SHAMSEER, L., D. MOHER, M. CLARKE, D. GHERSI, A. LIBERATI, M. PETTICREW, P. SHEKELLE, L. A. STEWART, AND G. 
PRISMA-P. 2015. PREFERRED REPORTING ITEMS FOR SYSTEMATIC REVIEW AND META-ANALYSIS PROTOCOLS (PRISMA-
P) 2015: ELABORATION AND EXPLANATION. BMJ 350: G7647. 
17. BIENAYMÉ, I.-J. 1853. CONSIDÉRATIONS À L’APPUI DE LA DÉCOUVERTE DE LAPLACE SUR LA LOI DE PROBABILITÉ DANS 
LA MÉTHODE DES MOINDRES CARRÉS. IMPRIMERIE DE MALLET-BACHELIER,  
18. VIECHTBAUER, W. 2010. CONDUCTING META-ANALYSES IN R WITH THE METAFOR PACKAGE. JOURNAL OF STATISTICAL 
SOFTWARE 36:  
19. TEAM, R. C. 2018. R: A LANGUAGE AND ENVIRONMENT FOR STATISTICAL COMPUTING. R FOUNDATION FOR STATISTICAL 
COMPUTING 2015, VIENNA, AUSTRIA.  
20. AIMETTI, M., F. ROMANO, N. GUZZI, AND G. CARNEVALE. 2012. FULL-MOUTH DISINFECTION AND SYSTEMIC 
ANTIMICROBIAL THERAPY IN GENERALIZED AGGRESSIVE PERIODONTITIS: A RANDOMIZED, PLACEBO-CONTROLLED 
TRIAL. J CLIN PERIODONTOL 39: 284-294. 
21. VARELA, V. M., D. HELLER, M. X. SILVA-SENEM, M. C. TORRES, A. P. COLOMBO, AND E. J. FERES-FILHO. 2011. SYSTEMIC 
ANTIMICROBIALS ADJUNCTIVE TO A REPEATED MECHANICAL AND ANTISEPTIC THERAPY FOR AGGRESSIVE 
PERIODONTITIS: A 6-MONTH RANDOMIZED CONTROLLED TRIAL. J PERIODONTOL 82: 1121-1130. 
22. HELLER, D., V. M. VARELA, M. X. SILVA-SENEM, M. C. TORRES, E. J. FERES-FILHO, AND A. P. COLOMBO. 2011. IMPACT OF 
SYSTEMIC ANTIMICROBIALS COMBINED WITH ANTI-INFECTIVE MECHANICAL DEBRIDEMENT ON THE MICROBIOTA OF 
GENERALIZED AGGRESSIVE PERIODONTITIS: A 6-MONTH RCT. J CLIN PERIODONTOL 38: 355-364. 
 12 
23. MESTNIK, M. J., M. FERES, L. C. FIGUEIREDO, P. M. DUARTE, E. A. LIRA, AND M. FAVERI. 2010. SHORT-TERM BENEFITS 
OF THE ADJUNCTIVE USE OF METRONIDAZOLE PLUS AMOXICILLIN IN THE MICROBIAL PROFILE AND IN THE CLINICAL 
PARAMETERS OF SUBJECTS WITH GENERALIZED AGGRESSIVE PERIODONTITIS. J CLIN PERIODONTOL 37: 353-365. 
24. DE LIMA OLIVEIRA, A. P., M. DE FAVERI, L. C. GURSKY, M. J. MESTNIK, M. FERES, A. D. HAFFAJEE, S. S. SOCRANSKY, AND 
R. P. TELES. 2012. EFFECTS OF PERIODONTAL THERAPY ON GCF CYTOKINES IN GENERALIZED AGGRESSIVE 
PERIODONTITIS SUBJECTS. J CLIN PERIODONTOL 39: 295-302. 
25. XAJIGEORGIOU, C., D. SAKELLARI, T. SLINI, A. BAKA, AND A. KONSTANTINIDIS. 2006. CLINICAL AND MICROBIOLOGICAL 
EFFECTS OF DIFFERENT ANTIMICROBIALS ON GENERALIZED AGGRESSIVE PERIODONTITIS. J CLIN PERIODONTOL 33: 254-
264. 
26. MATARAZZO, F., L. C. FIGUEIREDO, S. E. CRUZ, M. FAVERI, AND M. FERES. 2008. CLINICAL AND MICROBIOLOGICAL 
BENEFITS OF SYSTEMIC METRONIDAZOLE AND AMOXICILLIN IN THE TREATMENT OF SMOKERS WITH CHRONIC 
PERIODONTITIS: A RANDOMIZED PLACEBO-CONTROLLED STUDY. J CLIN PERIODONTOL 35: 885-896. 
27. SILVA, M. P., M. FERES, T. A. SIROTTO, G. M. SOARES, J. A. MENDES, M. FAVERI, AND L. C. FIGUEIREDO. 2011. CLINICAL 
AND MICROBIOLOGICAL BENEFITS OF METRONIDAZOLE ALONE OR WITH AMOXICILLIN AS ADJUNCTS IN THE 
TREATMENT OF CHRONIC PERIODONTITIS: A RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL. J CLIN 
PERIODONTOL 38: 828-837. 
28. MDALA, I., I. OLSEN, A. D. HAFFAJEE, S. S. SOCRANSKY, M. THORESEN, AND B. F. DE BLASIO. 2014. COMPARING CLINICAL 
ATTACHMENT LEVEL AND POCKET DEPTH FOR PREDICTING PERIODONTAL DISEASE PROGRESSION IN HEALTHY SITES OF 
PATIENTS WITH CHRONIC PERIODONTITIS USING MULTI-STATE MARKOV MODELS. J CLIN PERIODONTOL 41: 837-845. 
29. BADERSTEN, A., R. NILVEUS, AND J. EGELBERG. 1984. EFFECT OF NONSURGICAL PERIODONTAL THERAPY. II. SEVERELY 
ADVANCED PERIODONTITIS. J CLIN PERIODONTOL 11: 63-76. 
30. KALDAHL, W. B., K. L. KALKWARF, K. D. PATIL, M. P. MOLVAR, AND J. K. DYER. 1996. LONG-TERM EVALUATION OF 
PERIODONTAL THERAPY: I. RESPONSE TO 4 THERAPEUTIC MODALITIES. J PERIODONTOL 67: 93-102. 
31. MOMBELLI, A., P. BROCHUT, D. PLAGNAT, F. CASAGNI, AND C. GIANNOPOULOU. 2005. ENAMEL MATRIX PROTEINS AND 
SYSTEMIC ANTIBIOTICS AS ADJUNCTS TO NON-SURGICAL PERIODONTAL TREATMENT: CLINICAL EFFECTS. J CLIN 
PERIODONTOL 32: 225-230. 
32. MENDEZ, M., P. D. MELCHIORS ANGST, A. F. STADLER, R. V. OPPERMANN, AND S. GOMES. 2017. IMPACTS OF 
SUPRAGINGIVAL AND SUBGINGIVAL PERIODONTAL TREATMENTS ON ORAL HEALTH-RELATED QUALITY OF LIFE. 
INTERNATIONAL JOURNAL OF DENTAL HYGIENE 15: 135-141. 
 
 
 
 
